Related Experiment Video
Updated: Aug 14, 2026

Imaging of Estrogen Receptor-α in Rat Pial Arterioles using a Digital Immunofluorescent Microscope
Published on: November 29, 2011
Estrogen receptor-like macromolecule in MtTW15 rat pituitary tumors: effects of antiestrogens
Abstract:
To understand how estradiol-17 beta (E2) influences MtTW15 rat pituitary tumor function, we have evaluated the cytosolic E2 binding properties of tumors derived from control and steroid treated host animals. Specific E2 binding (approximately 3 pmoles/g tumor) was observed in all groups and was steroid responsive. The E2 binding macromolecule migrated to 7S following sucrose density gradient sedimentation and was specific for estrogenic steroids. Saturation analysis of E2 binding revealed a high affinity interaction (Kd = 5.5 +/- 0.5 x 10(-10) M). Furthermore, E2 binding was temperature-sensitive and degraded by trypsin. Thus, the MtTW15 tumor contains an estrogen receptor. Accordingly, the effects of 4 antiestrogenic drugs on tumor estrogen-receptor levels, tumor growth and hormone production were evaluated. In general, these drugs reduced cytosolic estrogen receptor levels, promoted tumor growth and increased tumor growth-hormone production. It is suggested that these compounds can exert both estrogen agonist and antagonist properties in MtTW15 tumors.
Insights
Estradiol-17 beta (E2) influences MtTW15 rat pituitary tumors by binding to an estrogen receptor. Antiestrogenic drugs affected receptor levels, promoting tumor growth and hormone production, suggesting mixed agonist/antagonist properties.
Area of Science:
- Endocrinology
- Molecular Biology
- Cancer Research
Background:
- Estradiol-17 beta (E2) is a key hormone influencing various physiological processes.
- Pituitary tumors, such as MtTW15, can exhibit hormone-dependent growth and function.
- Understanding hormone-receptor interactions is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the presence and characteristics of the estrogen receptor in MtTW15 rat pituitary tumors.
- To evaluate the impact of antiestrogenic drugs on estrogen receptor levels, tumor growth, and hormone production in this model.
Main Methods:
- Cytosolic E2 binding assays were performed on MtTW15 tumors.
- Sucrose density gradient sedimentation and saturation analysis were used to characterize the E2 binding macromolecule.
- The effects of four antiestrogenic drugs on tumor parameters were assessed.
Main Results:
- Specific, high-affinity estrogen binding (Kd = 5.5 x 10(-10) M) was detected in MtTW15 tumors.
- The E2 binding macromolecule exhibited characteristics of an estrogen receptor (7S, steroid-specific, temperature-sensitive, trypsin-degradable).
- Antiestrogenic drugs generally decreased receptor levels, promoted tumor growth, and increased growth hormone production.
Conclusions:
- MtTW15 rat pituitary tumors possess a functional estrogen receptor.
- The evaluated antiestrogenic compounds demonstrated both estrogen agonist and antagonist properties in this tumor model.
- These findings suggest complex hormonal regulation in pituitary tumors and potential therapeutic strategies.
More Related Videos
09:07Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019